EDAP TMS S.A. (NASDAQ:EDAP)
Industry: Healthcare

OFF LIST - 2419 consecutive market days: OFF LIST as of 10/25/2006 Through 11/14/2016

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. It operates in two divisions, High Intensity Focused Ultrasound (HIFU) and Urological Devices and Services (UDS). The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer. It also provides disposables, and leasing and treatment related services; and maintenance services. The UDS division develops, markets, manufactures, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders primarily urinary stones and other clinical indications. This segment offers Sonolith i-move and the Sonolith i-sys lithotripters for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. It also leases lithotripters; and sells disposables, spare parts, and maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is headquartered in Lyon, France.

Current Quote*
Last: $3.180
Change: 0.010
Book: $3.296
Volume: 21,462

As Of: 08/23 13:35 ET
*Quotes delayed by 20min.

Graphs for EDAP


3 Month Graph


6 Month Graph


1 Year Graph